A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS)

The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)

NCT01923428 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Trial for New Treatment of Adult Participants With Irritable Bowel Syndrome

NCT03721107 ·Status: COMPLETED ·Phase: PHASE2

Ibodutant for Relief of Irritable Bowel Syndrome (IRIS)

NCT00761007 ·Status: COMPLETED ·Phase: PHASE2

IQP-CL-101 in IBS Management

NCT01774825 ·Status: COMPLETED ·Phase: PHASE3

A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.

NCT00139672 ·Status: COMPLETED ·Phase: PHASE2

Ethosuximide to Treat IBS

NCT02973542 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety, Tolerability of GA-AT0119 in IBS-C

NCT05240521 ·Status: UNKNOWN ·Phase: NA

A Study of BMS-562086 in Patients With Irritable Bowel Syndrome

NCT00399438 ·Status: COMPLETED ·Phase: PHASE2

A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679

NCT00511563 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety of IBS Digital Behavioral Treatment

NCT04133519 ·Status: COMPLETED ·Phase: NA

A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers

NCT02727283 ·Status: COMPLETED ·Phase: PHASE1

Administration of a Molecular Complex of Resins, Polysaccharides and Polyphenols in Irritable Bowel Syndrome.

NCT05016024 ·Status: COMPLETED ·Phase: NA

Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS)

NCT00130741 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacy-based Study to Learn More About How Well Iberogast Works, How it Affects the Body, How it is Used, and User Satisfaction in Patients With Functional and Motility-related (Stomach and Bowel Movement-related) Gastrointestinal Diseases, Including Irritable Bowel Syndrome

NCT04993989 ·Status: COMPLETED

Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide

NCT01678781 ·Status: COMPLETED

A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients

NCT01225237 ·Status: COMPLETED ·Phase: PHASE4

Pain Relief In Irritable Bowel Syndrome

NCT02573844 ·Status: COMPLETED ·Phase: PHASE4

Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)

NCT00101985 ·Status: COMPLETED ·Phase: PHASE2

Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D)

NCT01303224 ·Status: COMPLETED ·Phase: PHASE2

Postinfectious Irritable Bowel Syndrome and Gelsectan

NCT05045768 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel Syndrome

NCT00135031 ·Status: COMPLETED ·Phase: PHASE3

Diarrhea Predominant Irritable Bowel Syndrome in Females

NCT00461526 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c

NCT00215566 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

NCT03977155 ·Status: COMPLETED ·Phase: PHASE2

Investigation of Efficacy and Safety of PPC-5650 to Experimental Induced Sensation and Pain in the Rectosigmoid

NCT01449487 ·Status: COMPLETED ·Phase: PHASE1